Conformal High Dose Rate Brachytherapy Improves Biochemical Control And Cause Specific Survival in Patients With Prostate Cancer And Poor Prognostic Factors-Reference-Cited by-同舟云学术

Conformal High Dose Rate Brachytherapy Improves Biochemical Control And Cause Specific Survival in Patients With Prostate Cancer And Poor Prognostic Factors

Published:2003-03 Issue:3 Volume:169 Page:974-980
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

MARTINEZ ALVARO¹,GONZALEZ JOSE¹,SPENCER WILLIAM¹,GUSTAFSON GARY¹,KESTIN LARRY¹,KEARNEY DAVID¹,VICINI FRANK A.¹

Affiliation:

1. From the Departments of Radiation Oncology and Urology, William Beaumont Hospital, Royal Oak, Michigan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer;Morgan;Urology,1993

2. Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis;Gerber;Eur Urol,1997

3. A ten-year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States;Hanks;Int J Radiat Oncol Biol Phys,1987

4. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-35;Pilepich;J Clin Oncol,1997

5. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin;Bolla;N Engl J Med,1997

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose-rate brachytherapy as monotherapy versus as boost in unfavorable intermediate-risk localized prostate cancer: A matched-pair analysis;Brachytherapy;2023-09

2. High‐dose‐rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome;Cancer Reports;2021-06-23

3. A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate;Frontiers in Oncology;2019-12-10

4. Overview of Tumor Control Outcomes with Prostate SBRT for Low and Intermediate Risk Prostate Cancer and Comparison to Other Treatment Interventions;Stereotactic Radiosurgery for Prostate Cancer;2018-09-29

5. Quality of life up to 10 years after external beam radiotherapy and/or brachytherapy for prostate cancer;Brachytherapy;2018-05